John Chi On Ho
Known title: DirectorCIK: 0001865775
Associated companies
Transaction History
| AVPT | ▲ Buy | Grant | 16,493 | $190K | 6/1/2026 | View on chart |
| AVPT | ▼ Sell | Open Market | 650,000 | $9.9M | 9/18/2025 | View on chart |
| AVPT | ▲ Buy | Grant | 9,744 | $175K | 6/20/2025 | View on chart |
| AVPT | ▲ Buy | Grant | 23,371 | $415K | 12/20/2024 | View on chart |
| AVPT | ▲ Buy | Grant | 23,371 | $433K | 12/10/2024 | View on chart |
| AVPT | ▲ Buy | Grant | 23,392 | $426K | 12/10/2024 | View on chart |
| AVPT | ▲ Buy | Grant | 19,189 | $175K | 6/3/2024 | View on chart |
| AVPT | ▲ Buy | Grant | 26,636 | $175K | 6/1/2023 | View on chart |
| AVPT | ▲ Buy | Grant | 16,598 | $0 | 9/1/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 11, 2026
AvePoint Reports 27% ARR Growth, Margins Stay Soft
AvePoint said its annual recurring revenue grew 27% in the latest quarter, a strong sign of customer demand. However, the company’s adjusted margins did not rise in line with revenue, raising questions about cost control. New analyst coverage from BMO and a Lockheed Martin analyst has highlighted the company’s AI initiatives and set a price target of $17, reflecting optimism about its long‑term cash flow potential.
AvePoint Reports 27% ARR Growth, Margins Stay Soft. AvePoint said its annual recurring revenue grew 27% in the latest quarter, a strong sign of customer demand. However, the company’s adjusted margins did not rise in line with revenue, raising questions about cost control. New analyst coverage from BMO and a Lockheed Martin analyst has highlighted the company’s AI initiatives and set a price target of $17, reflecting optimism about its long‑term cash flow potential.